Paulo Gustavo Kotze Selected Research

Paulo Gustavo Kotze Research Topics

Disease

40	Crohn Disease (Crohn's Disease) 10/2022 - 04/2010
25	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 10/2014
16	Ulcerative Colitis 10/2022 - 10/2013
5	Fistula 11/2021 - 01/2018
4	Colitis 05/2022 - 02/2018
4	Inflammation (Inflammations) 01/2021 - 02/2018
4	Necrosis 11/2020 - 01/2017
3	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2019
3	Rheumatoid Arthritis 04/2018 - 09/2015
2	Hypoalbuminemia 01/2019 - 01/2017
2	Sepsis (Septicemia) 01/2019 - 12/2016
2	Neoplasms (Cancer) 02/2018 - 01/2017
2	Celiac Disease (Celiac Sprue) 07/2010 - 04/2010
1	Abdominal Pain (Pain, Abdominal) 10/2022
1	Pouchitis 01/2022
1	Anemia 01/2021
1	Abdominal Abscess 01/2021
1	Venous Thromboembolism 09/2020
1	Short Bowel Syndrome 01/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Infections 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2018
1	Obesity 01/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Injection Site Reaction 12/2017
1	Anastomotic Leak 12/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2016
1	Autoimmune Diseases (Autoimmune Disease) 09/2015
1	Ankylosing Spondylitis 09/2015
1	Psoriatic Arthritis 09/2015
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2015
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2015
1	Pain (Aches) 03/2014
1	Postoperative Pain 03/2014
1	Sarcoidosis (Schaumann Disease) 12/2013
1	Proctocolitis (Hemorrhagic Proctocolitis) 10/2013

Drug/Important Bio-Agent (IBA)

12	Infliximab (Remicade)FDA Link 07/2021 - 12/2013
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2021 - 01/2017
8	Adalimumab (Humira)FDA Link 07/2021 - 12/2013
7	Pharmaceutical PreparationsIBA 10/2022 - 04/2018
7	vedolizumabIBA 08/2022 - 01/2016
4	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022 - 12/2013
4	Ustekinumab (CNTO 1275)FDA Link 08/2022 - 01/2018
4	Biological ProductsIBA 05/2022 - 01/2016
4	SteroidsIBA 01/2021 - 12/2016
3	Biosimilar PharmaceuticalsIBA 01/2019 - 01/2015
2	C-Reactive ProteinIBA 10/2022 - 07/2017
2	tofacitinibIBA 08/2022 - 04/2018
2	AntibodiesIBA 11/2020 - 07/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2020 - 01/2019
2	IntegrinsIBA 04/2018 - 01/2018
2	Monoclonal AntibodiesIBA 12/2017 - 09/2015
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 08/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	CateninsIBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	Sucralfate (Carafate)FDA LinkGeneric 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Serum AlbuminIBA 01/2019
1	AlbuminsIBA 01/2019
1	CytokinesIBA 04/2018
1	Janus KinasesIBA 04/2018
1	CarbohydratesIBA 01/2018
1	IncretinsIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	InterleukinsIBA 07/2017
1	LipopolysaccharidesIBA 07/2017
1	Toll-Like Receptor 4IBA 07/2017
1	SmokeIBA 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2016
1	Proteins (Proteins, Gene)FDA Link 09/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	meta-cresolsulfonic acid drug combination formaldehydeIBA 03/2014
1	Dibucaine (Cinchocaine)IBA 03/2014
1	Azathioprine (Imuran)FDA LinkGeneric 12/2013
1	Mesalamine (Mesalazine)FDA LinkGeneric 10/2013
1	TabletsIBA 10/2013
1	Immunoglobulin G (IgG)IBA 07/2010
1	Immunoglobulin A (IgA)IBA 07/2010

Therapy/Procedure

27	Therapeutics 10/2022 - 10/2013
9	Biological Therapy 01/2022 - 07/2015
3	Colectomy 11/2021 - 02/2018
3	Operative Surgical Procedures 01/2019 - 12/2016
2	Colostomy 01/2021 - 01/2021
2	Ostomy 01/2021 - 01/2020
1	Precision Medicine 12/2021
1	Minimally Invasive Surgical Procedures 05/2021
1	Ileostomy 01/2021
1	Enema (Enemas) 01/2021
1	Restorative Proctocolectomy 01/2020
1	Elective Surgical Procedures 10/2019
1	Bariatric Surgery 01/2018
1	Blood Transfusion (Blood Transfusions) 12/2016
1	Hemorrhoidectomy 03/2014
1	Remission Induction 10/2013